PMC6489098_01
Clinical findings. a, b Patient 1. Diffuse hair loss started covering her whole scalp 6 months after starting secukinumab for the treatment of moderate type psoriasis vulgaris (a). Hair loss was stopped and the patient recovered from alopecia by the supplementation of 10 mg oral prednisolone (b). c, d Patient 2. Alopecia diffusa started after 2 months of brodalumab treatment for moderate type psoriasis vulgaris (c). The patient's medication was changed to ustekinumab, and her hair recovered without the administration of oral immune suppressants (d).
cde-0011-0082-g01.jpg
PMC6489098_02_cde-0011-0082-g01.jpg
F1
Her skin eruption disappeared quickly, but alopecia diffusa started after 2 months (Fig. 1c). We changed her medication to ustekinumab, an IL-12/23 p40 inhibitor, and her hair recovered without the administration of oral immune suppressants (Fig. 1d).
PMC6489098_02
Clinical findings. a, b Patient 1. Diffuse hair loss started covering her whole scalp 6 months after starting secukinumab for the treatment of moderate type psoriasis vulgaris (a). Hair loss was stopped and the patient recovered from alopecia by the supplementation of 10 mg oral prednisolone (b). c, d Patient 2. Alopecia diffusa started after 2 months of brodalumab treatment for moderate type psoriasis vulgaris (c). The patient's medication was changed to ustekinumab, and her hair recovered without the administration of oral immune suppressants (d).
cde-0011-0082-g01.jpg
PMC6489098_02_cde-0011-0082-g01.jpg
F1
Her skin eruption disappeared quickly, but alopecia diffusa started after 2 months (Fig. 1c). We changed her medication to ustekinumab, an IL-12/23 p40 inhibitor, and her hair recovered without the administration of oral immune suppressants (Fig. 1d).